Literature DB >> 6153860

Group B streptococcal infections.

C J Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6153860

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN： 0065-2822


× No keyword cloud information.
  28 in total

1.  Mutually exclusive distribution of IS1548 and GBSi1, an active group II intron identified in human isolates of group B streptococci.

Authors:  M Granlund; F Michel; M Norgren
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 2.  Nutritional modulation of phagocyte function with special emphasis on the newborn.

Authors:  M C Harris; S D Douglas
Journal:  Indian J Pediatr       Date:  1990 Mar-Apr       Impact factor: 1.967

3.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Properties of group B streptococci with protein surface antigens X and R.

Authors:  I W Wibawan; C Lämmler
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 5.  Neonatal septicemia.

Authors:  A C Kuruvilla
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

6.  Neonatal septicemia.

Authors:  S P Khatua; A K Das; B D Chatterjee; S Khatua; B Ghose; A Saha
Journal:  Indian J Pediatr       Date:  1986 Jul-Aug       Impact factor: 1.967

7.  Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Authors:  T Lagergard; J Shiloach; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

8.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  M R Wessels; L C Paoletti; A K Rodewald; F Michon; J DiFabio; H J Jennings; D L Kasper
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Endocarditis caused by a group B Streptococcus strain, type III, in a nonencapsulated phase.

Authors:  M Sellin; M Linderholm; M Norgren; S Håkansson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.